Subscribe to RSS or

Viacord

Call one of our Specialists 866.668.4895
Outside U.S. call 617.914.3900

The value of cord blood—even greater than once imagined!

Copy of unlock potentialThis month, researchers at the Salk Institute for Biological Studies are reporting that umbilical cord blood can be used to make induced pluripotent stem cells (iPS)—that are immunologically immature with properties similar to human embryonic stem cells.

Embryonic stem cells are of considerable scientific interest because they are “totipotent” —meaning they have the ability to generate all cell types within the human body and form embryos. For these reasons, they hold remarkable potential for regenerative medicine—the ability to unlock the body’s potential to repair and regrow cells and tissues that may be damaged by trauma or disease.

But the political and ethical debate around embryonic stem cells makes them controversial…

With the Salk Institute’s scientific breakthrough, cord blood induced pluripotent stem cells (CBiPS) may now become the gold standard as the foundation in stem cell therapies. According to Dr. Juan-Carlos Izpisúa Belmonte, a professor at the Salk Institute’s Gene Expression Laboratory who led the recent study, “Cord blood stem cells could serve as a safe, “ready-to-use” source for the generation of iPS cells, since they are easily accessible, immunologically immature and quick to return to an embryonic stem cell-like state.”

What does this mean for families who have banked or are considering banking their child’s cord blood?

Families who have banked your child’s cord blood (or are considering it) take note -you may have access to “ready-to-use” stem cell therapies that are greater than we imagined. This includes treatments that may help restore, repair and regenerate various tissues and organs that may have been damaged through injury or illness.

Today, cord blood stem cells are already being used to successfully treat nearly 80 life-threatening diseases  and early indications from clinical studies in regenerative therapies for Cerebral Palsy and Type I Diabetes are encouraging. The recent findings from the Salk Institute only strengthen the potential that cord blood stem cells are likely to provide a treasure trove of possibilities for the future.

Tell us, how do you feel about the Salk Institute’s findings about cord blood induced pluripotent stem cells (CBiPS)?

Share:
  • Print this article!
  • Digg
  • FriendFeed
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • NewsVine
  • Propeller
  • Technorati

To automatically receive our blog posts, sign-up to receive e-mail or register for our RSS feed.